Results 101 to 110 of about 1,385 (194)

Interleukin-6 in Castleman disease subtypes: look to tissues, not just blood [PDF]

Not ...
Luke Y.C. Chen, Mariam Goubran
core   +2 more sources

Pathophysiology, Treatment, and Prognosis of Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome: A Review

Current Issues in Molecular Biology
TAFRO syndrome, first reported in 2010, is a systemic inflammatory disease with a rapid onset and potentially fatal course if not treated promptly and appropriately.
Takuya Kakutani, Riko Kamada, Yotaro Tamai   +2 more
doaj   +1 more source

Internal psychometric validation of an international burden of illness survey for idiopathic multicentric Castleman disease [PDF]

Introduction: Idiopathic multicentric Castleman disease (iMCD) is a rare, chronic, debilitating lymphoproliferative disorder where the mainstay of treatment is symptom management.
Brazier, J., Franklin, M., Jones, E., Mason, N., Mukherjee, S., Shupo, F., Wayi-Wayi, G., Zibelnik, N.   +7 more
core   +1 more source

IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE

Haematologica
Idiopathic multicentric Castleman disease (IMCD) is a rare and complex lymphoproliferative disorder characterized by excessive growth of polyclonal, reactive lymphoid cells in multiple lymph nodes, often associated with systemic symptoms such as fever ...
S. Ferrero, A. Di Napoli
doaj  

The value of a PET scan in selecting the best lymph node to biopsy, and confirming the diagnosis of idiopathic multicentric Castleman disease with HLH and EBV viremia in a previously healthy adult [PDF]

Introduction: Castleman disease (CD) is a rare lymphoproliferative disorder having a variegated clinical presentation. Diagnosis of the idiopathic HIV- and HHV8-negative multicentric CD (iMCD) subtype poses a challenge given its non-specific clinical ...
Erica Bitektine, Hamila Hagh-Daoust, Jean-Pierre Routy, René P. Michel, Stephane Isnard   +4 more
core   +2 more sources

Single-cell landscape of idiopathic Multicentric Castleman Disease in identical twins.

Blood
Idiopathic Multicentric Castleman Disease (iMCD) is a rare cytokine-driven disorder characterized by systemic inflammation, generalized lymphadenopathy and organ dysfunction.
Jason Yongsheng Chan, J. Loh, J. Lim, H. Liany, E. Lee, J. Y. Lee, B. Kannan, B. Y. Lim, Zexi Guo, K. Lim, J. Ha, Cedric CY Ng, T. Ko, Dachuan Huang, D. Y. Seow, Chee Leong Cheng, S. H. Chan, J. Ngeow, Bin Tean Teh, Soon Thye Lim, C. Ong   +20 more
semanticscholar   +1 more source

Characterizing the heterogeneity of Castleman disease and oligocentric subtype: findings from the ACCELERATE registry

Blood Advances
: Castleman disease (CD) describes a group of rare lymphoproliferative disorders that exhibit a wide range of symptomatology and degree of lymphadenopathy, particularly across the 2 forms of CD with unknown etiology, unicentric CD (UCD), and human ...
Sheila K. Pierson, Joshua D. Brandstadter, Drew A. Torigian, Adam Bagg, Mary Jo Lechowicz, Daisy Alapat, Corey Casper, Amy Chadburn, Shanmuganathan Chandrakasan, Angela Dispenzieri, Alexander Fosså, Christian Hoffmann, Makoto Ide, Razelle Kurzrock, Sudipto Mukherjee, Sunita Nasta, José-Tomás Navarro, Ariela Noy, Eric Oksenhendler, Mateo Sarmiento Bustamante, Saishravan Shyamsundar, Matthew Streetly, Raymond S. M. Wong, Lu Zhang, Megan S. Lim, Gordan Srkalovic, Frits van Rhee, David C. Fajgenbaum   +27 more
doaj   +1 more source

Tacrolimus Treatment for TAFRO Syndrome

Biomedicines
TAFRO syndrome is an acute systemic inflammatory disorder characterized by thrombocytopenia, anasarca, fever, reticulin myelofibrosis, renal dysfunction, and organomegaly.
Taiichiro Shirai, Shinya Ichikawa, Jun Saegusa   +2 more
doaj   +1 more source

Poster Sessions

HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

An unusual case of HHV-8 negative, idiopathic, multicentric Castleman disease following chronic lymphocytic leukaemia

European Journal of Case Reports in Internal Medicine
Background: Castleman disease is a rare condition characterised by polytypic lymphocytes proliferation and lymphadenopathy generally with a benign course.
Pierre-Yves Sansen, Hélène Vellemans, Julien Depaus, Caroline Fervaille, Benoit Krug, Anne Sonet, Elodie Collinge   +6 more
doaj   +1 more source